BioCentury
ARTICLE | Clinical News

cAd-EBOZ: Preliminary Phase II data

April 6, 2015 7:00 AM UTC

Preliminary data from >600 healthy volunteers in the Phase II portion of the double-blind, placebo-controlled, Liberian Phase II/III PREVAIL trial showed that a single injection of cAd-EBOZ or VSV-ZE...